The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation

Published:2016-10 Issue:10 Volume:22 Page:1747-1757
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Funder

National Heart, Lung, and Blood Institute and National Cancer Institute

National Cancer Institute, National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases

Health Resources and Services Administration

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference68 articles.

1. Clinical trials of hematopoietic cell transplantations: current needs and future strategies;O'Reilly;Biol Blood Marrow Transplant,2000

2. Blood and Marrow Transplant Clinical Trials Network (BMT CTN): addressing unanswered questions;Weisdorf;Biol Blood Marrow Transplant,2007

3. Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study;Anderlini;Lancet Haematol,2015

4. Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels;Tolar;Biol Blood Marrow Transplant,2012

5. Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Building a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular Immunotherapies;Journal of Clinical Oncology;2021-02-10

2. Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network;Biology of Blood and Marrow Transplantation;2020-05

3. Less Is Not Necessarily More: Toward a Rational Selection of the Conditioning Regimen in Acute Myeloid Leukemia;Journal of Clinical Oncology;2020-04-20

4. The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience;British Journal of Haematology;2019-12-10

5. Current status and future clinical directions in the prevention and treatment of relapse following hematopoietic transplantation for acute myeloid and lymphoblastic leukemia;Bone Marrow Transplantation;2018-05-31